Table 1. Model parameters.
Parameter | Realistic Value | Description | Reference |
n | 1–8 | Number of epitopes recognized during first 100 days | [11], [13], [30], [31] |
m | 2–10 | Number of sites per epitope important for recognition | [11], [13], [30], [31] |
1 | Rate at which activated target cells transition out of the highly infectable phase | [46], [68] | |
cells | Activated target cell level | [47], [69], [70] | |
1 | Virus-induced infected cell death rate | [55] | |
4 | CTL-induced infected cell death rate | [47], [69], [70] | |
β | Basic efficiency of target cell infection | [47], [69], [70] | |
s | Intrinsic mutation cost | [10], [21], [22], [27]–[29] | |
α | Reduction of CTL recognition | [27]–[29] | |
Fractional reduction in intrinsic replication rate | |||
Fractional reduction of CTL recognition | |||
CTL killing efficiency. Gives CTLs in chronic infection | [45] | ||
cells | Initial population of CTLs | [69] | |
c | 1 | Maximum growth rate of effector cells | [69] |
0.1 | Death rate of effector cells | [47], [69], [70] | |
cells | Number of recognized infected cells for half maximal proliferation of CTL (inverse avidity). Gives an infected cell level of in chronic infection | [44] |
Model parameters for the model of escape from multiple CTL shown in Figure 1.